The net profit of Orient Venture (600278.sh) in 2021 will increase by 23.13%-60.45%
Oriental Venture (600278.SH) announced that the company expects the net profit attributable to shareholders of listed companies in 2021 to be 330 million yuan to 430 million yuan, an increase of 62 million yuan to 162 million yuan compared to the same period last year, a year-on-year growth of 23.13% to 60.45%.The company expects the net profit excluding non-recurring gains and losses attributable to shareholders of listed companies in 2021 to be 205-305 million yuan, an increase of 444-144 million yuan compared to the same period last year, a year-on-year growth of 27.33%-89.44%.The main reasons for the pre-increase in performance are as follows: 1. Affected by market factors in 2021, the performance of enterprises related to the logistics sector of the company will increase significantly on a year-on-year basis.2. In 2021, Shanghai Dongsong Medical Technology Co., LTD., the core enterprise in the big health sector of the company, will continue to maintain steady growth in benefits through deepening and expanding professional services.3. In February 2021, the company completed the acquisition of 100% equity of Shanghai Kangjian Import & Export Co., LTD. Kangjian became a wholly-owned subsidiary of the company and was included in the accounting scope of the company’s consolidated statements, which also had a positive impact on the company’s operating revenue and profit.